Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00074763 · ClinicalTrials.gov registry record · Phase 3
Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets
A Phase 3 study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 4
- Enrollment target
NCT00074763: Clinical Trial Phase 3 study, sponsored by M.D. Anderson Cancer Center.
NCT00074763 is a Phase 3 study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00074763, a Phase 3 study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 4 participants
- Enrollment target
Study Summary
Objectives: * Determine the corrected count increment of autologous transfused platelets that had been stored by cryopreservation with ThromboSol. * Determine the ability of autologous platelets that had been stored by cryopreservation with ThromboSol to correct thrombocytopenia.
Interventions
- BIOLOGICAL Platelet Transfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2003-07 |
| Est. Completion | 2006-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00074763
The ClinicalTrials.gov registry entry for NCT00074763 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Platelet Transfusion is the first listed.
NCT00074763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00074763 about?
NCT00074763 is a clinical study titled "Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets". Objectives: * Determine the corrected count increment of autologous transfused platelets that had been stored by cryopreservation with ThromboSol. * Determine the ability of autologous platelets that had been stored by cryopreservation with ThromboSol to correct thrombocytopenia.
What is the current status of trial NCT00074763?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 4 participants. The study started on 2003-07. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00074763?
The interventions under investigation include: Platelet Transfusion (BIOLOGICAL).
Who is sponsoring clinical trial NCT00074763?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.